Carolyn Riley Chapman
Biographic Data
| ID | 7519339 |
|---|---|
| NAME | Carolyn Riley Chapman |
| GIVEN NAMES | Carolyn Riley |
| FAMILY NAME | Chapman |
| SIGNATURE | CHAPMAN C R |
| AFFILIATIONS | Brigham and Women's Hospital |
| ORCID | 0000-0002-8793-6412 |
| VERIFIED | Yes |
| TOTAL WORKS | 6 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 6 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2019 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Toward Justice and Community Empowerment in Genomics Studies on Sensitive Traits
Community engagement and participatory research have been appropriately employed to increase the relevance, rigor, and acceptability of all types of research, but these approaches may be particularly important in genomics and biomedical research on sensitive traits such as neurodevelopmental, psychiatric, and behavioral ones. Here, we provide an overview of past and ongoing efforts in community engagement in genomics studies and consider successe…
The Occasional Human Sacrifice
Primary duty is to communicate moment-in-time nature of genetic variant interpretation
As Gods
Federal Right to Try
Policy‐makers, bioethicists, and patient advocates have been engaged in a fierce battle about the merits and potential harms of a federal right‐to‐try law. This debate about access to investigational medical products has raised profound questions about the limits of patient autonomy, appropriate government regulation, medical paternalism, and political rhetoric. For example, do patients have a right to access investigational therapies, as the rig…
How Should Physicians Respond When They Learn Patients Are Using Unapproved Gene Editing Interventions
Hundreds of gene therapies are currently in various stages of research and development. A subset of these involve gene editing technologies such as CRISPR. In this hypothetical case, a patient with chronic pain has initiated a CRISPR-based intervention obtained from a clinic in the Cayman Islands. His physician doubts it is approved by the US Food and Drug Administration and worries about its safety. The case presents ethical questions about pote…
No prominent works on this page.
Federal Right to Try
Policy‐makers, bioethicists, and patient advocates have been engaged in a fierce battle about the merits and potential harms of a federal right‐to‐try law. This debate about access to investigational medical products has raised profound questions about the limits of patient autonomy, appropriate government regulation, medical paternalism, and political rhetoric. For example, do patients have a right to access investigational therapies, as the rig…
How Should Physicians Respond When They Learn Patients Are Using Unapproved Gene Editing Interventions
Hundreds of gene therapies are currently in various stages of research and development. A subset of these involve gene editing technologies such as CRISPR. In this hypothetical case, a patient with chronic pain has initiated a CRISPR-based intervention obtained from a clinic in the Cayman Islands. His physician doubts it is approved by the US Food and Drug Administration and worries about its safety. The case presents ethical questions about pote…
As Gods
Primary duty is to communicate moment-in-time nature of genetic variant interpretation
Toward Justice and Community Empowerment in Genomics Studies on Sensitive Traits
Community engagement and participatory research have been appropriately employed to increase the relevance, rigor, and acceptability of all types of research, but these approaches may be particularly important in genomics and biomedical research on sensitive traits such as neurodevelopmental, psychiatric, and behavioral ones. Here, we provide an overview of past and ongoing efforts in community engagement in genomics studies and consider successe…
The Occasional Human Sacrifice
Ethics in Clinical Research (4 works) · Biology (3 works) · Biomedical Ethics and Regulation (3 works) · Political science (3 works) · Psychology (3 works) · Computer Science (2 works) · Economics (2 works) · Genetics (2 works) · Law (2 works) · Law and economics (2 works)